These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 413151)

  • 1. Interaction between narcotic antagonist (naloxone) and lysergic acid diethylamide (LSD) in the rat.
    Fertziger AP; Fischer R
    Psychopharmacology (Berl); 1977 Nov; 54(3):313-4. PubMed ID: 413151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dopaminergic and cholinergic drugs. naloxone and l-prolyl-leucyl-glycinamide on LSD-induced catalepsy.
    Chiu S; Mishra RK
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Aug; 313(1):45-50. PubMed ID: 6111027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naloxone enhancement of DMT and LSD-25 induced suppression of food-rewarded bar pressing behavior in the rat.
    Ruffing D; Kovacic B; Demetriou S; Domino EF
    Psychopharmacology (Berl); 1979 Apr; 62(3):207-10. PubMed ID: 111285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of selected opioid agonists and antagonists on DMT- and LSD-25-induced disruption of food-rewarded bar pressing behavior in the rat.
    Ruffing DM; Domino EF
    Psychopharmacology (Berl); 1981; 75(3):226-30. PubMed ID: 6798611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of naloxone on the effects of LSD in monkeys.
    Hadorn DC; Anistranski JA; Connor JD
    Neuropharmacology; 1984 Nov; 23(11):1297-300. PubMed ID: 6527737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of dermorphin-induced catalepsy with naloxone, TRH-analog CG3703 and the benzodiazepine antagonist, Ro 15-1788.
    Paakkari P; Feuerstein G
    Neuropharmacology; 1988 Oct; 27(10):1007-12. PubMed ID: 2907115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the stimulus effects of morphine and lysergic acid diethylamide (LSD).
    Hirschhorn ID; Rosecrans JA
    Pharmacol Biochem Behav; 1974 May; 2(3):361-6. PubMed ID: 4837907
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of dopamine agonists and an opiate antagonist on agaricus-induced catalepsy, as tested by a new method.
    Sukul NC; Klemm WR
    Arch Int Pharmacodyn Ther; 1988; 295():40-51. PubMed ID: 2907723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naloxone alters the effects of LSD, DOM and quipazine on operant behavior of rats.
    Mokler DJ; Commissaris RL; Henck JW; Rech RH
    Pharmacol Biochem Behav; 1984 Sep; 21(3):333-7. PubMed ID: 6593750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperthermic effects of D-lysergic acid diethylamide (LSD) and its derivatives in rabbits and rats.
    Hashimoto H; Hayashi M; Nakahara Y; Niwaguchi T; Ishii H
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):314-21. PubMed ID: 303504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Turning in MFB-lesioned rats and antagonism of neuroleptic-induced catalepsy after lisuride and LSD.
    Pieri M; Schaffner R; Pieri L; Da Prada M; Haefely W
    Life Sci; 1978 May; 22(18):1615-22. PubMed ID: 307642
    [No Abstract]   [Full Text] [Related]  

  • 12. Opioid-hallucinogen interactions.
    Domino EF
    Pharmacol Biochem Behav; 1986 Feb; 24(2):401-5. PubMed ID: 3006089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of D-lysergic acid diethylamide on striatal choline acetyltransferase activity in the rat.
    Wong YW; Chiu S; Mishra RK
    Biochem Pharmacol; 1979 Jul; 28(14):2207-9. PubMed ID: 40557
    [No Abstract]   [Full Text] [Related]  

  • 14. Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.
    Burris KD; Sanders-Bush E
    Mol Pharmacol; 1992 Nov; 42(5):826-30. PubMed ID: 1359397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A correlative evaluation of cyclazocine, LSD and naloxone on continuous discriminated avoidance in rats.
    Wray SR
    Psychopharmacologia; 1972; 26(1):29-43. PubMed ID: 5051460
    [No Abstract]   [Full Text] [Related]  

  • 16. Naloxone and propranolol inhibit the disruption of the hippocampal theta waves induced by D-lysergic acid diethylamide in the rabbit.
    Ortolani E; de Maria G; Palazzesi S
    Pharmacol Biochem Behav; 1986 Feb; 24(2):183-6. PubMed ID: 3952108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LSD-induced alterations of investigatory responding in rats.
    Geyer MA; Light RK
    Psychopharmacology (Berl); 1979 Sep; 65(1):41-7. PubMed ID: 41281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex.
    Gresch PJ; Smith RL; Barrett RJ; Sanders-Bush E
    Neuropsychopharmacology; 2005 Sep; 30(9):1693-702. PubMed ID: 15756304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of histaminergic mechanisms in the cataleptogenic effect of morphine in mice.
    Muley MP; Balsara JJ; Jadhav JH; Chandorkar AG
    J Pharm Pharmacol; 1982 Jan; 34(1):34-7. PubMed ID: 6121029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the action of lysergic acid diethylamide and apomorphine on the copulatory response in the female rat.
    Eliasson M; Meyerson BJ
    Psychopharmacology (Berl); 1976 Sep; 49(3):301-6. PubMed ID: 826947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.